Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Surface Transforms (SCE) by Steve Moore in ShareProphets
- Buy InterContinental Hotels Group (IHG) by Bank of America
- Hold GSK (GSK) by DZ Bank
- Neutral Intertek Group (ITRK) by Goldman Sachs
- Neutral InterContinental Hotels Group (IHG) by Goldman Sachs
- Overweight Tesco (TSCO) by Barclays
- Sector Perform SIG (SHI) by RBC Capital
- Outperform Lancashire Holdings Limited (LRE) by RBC Capital
- Sector Perform Hiscox Limited (DI) (HSX) by RBC Capital
- Outperform Grafton Group Ut (CDI) (GFTU) by RBC Capital
- Buy Team17 Group (TM17) by Citi
- Overweight Persimmon (PSN) by JP Morgan
- Overweight Taylor Wimpey (TW.) by JP Morgan
- Overweight Barratt Developments (BDEV) by JP Morgan
- Overweight Rightmove (RMV) by JP Morgan
- Buy Trainline (TRN) by Shore Capital
- Overweight Vistry Group (VTY) by JP Morgan
- Buy Smiths News (SNWS) by Berenberg
- Buy Johnson Service Group (JSG) by Peel Hunt
- Hold Oxford Biomedica (OXB) by Deutsche Bank
4basebio (4BB) Share Price
Health Care Sector
NOTE: This is based on 0 open tips for 4basebio (4BB)
| Latest Bid : 1,060.00p | Latest Ask : 1,100.00p |
| High Today : 1,090.00p | Low Today : 1,080.00p |
| This Years High : 1,120.00p | This Years Low : 500.00p |
| Volume : 0 | MKT Cap : £132M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
4basebio (4BB) Overview
4basebio UK Societas ("4bb" or "the Company") is a specialist life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effective and safe delivery of these DNA based products to patients. Its main country of operation is the UK. It is the intention of the Company to become a market leader in the manufacture and supply of high purity, synthetic DNA for research, therapeutic and pharmacological use. The principal objective of 4bb is to validate and scale its DNA synthesis process with a view to manufacturing Good Manufacturing Practice ("GMP") grade DNA, suitable for use in gene therapies and DNA vaccines.4basebio (4BB) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 1,060.00p | Latest Ask : 1,100.00p |
| High Today : 1,090.00p | Low Today : 1,080.00p |
| This Years High : 1,120.00p | This Years Low : 500.00p |
| Volume : 0 | MKT Cap : £132M |
4basebio Overview
4basebio UK Societas ("4bb" or "the Company") is a specialist life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effective and safe delivery of these DNA based products to patients. Its main country of operation is the UK. It is the intention of the Company to become a market leader in the manufacture and supply of high purity, synthetic DNA for research, therapeutic and pharmacological use. The principal objective of 4bb is to validate and scale its DNA synthesis process with a view to manufacturing Good Manufacturing Practice ("GMP") grade DNA, suitable for use in gene therapies and DNA vaccines.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.